Summary
A 30-year-old financial analyst was granted a security clearance despite concerns under Guideline E (Personal Conduct) and Guideline H (Drug Involvement). The Statement of Reasons alleged the applicant falsified his e-QIP by denying illegal drug use, specifically purchasing and using marijuana from approximately 2010 through December 2020, and after submitting his e-QIP on December 2, 2020. It was also alleged he intended to continue using marijuana.
The applicant admitted to past marijuana use, explaining he misunderstood the difference between state and federal law regarding its legality. However, he denied any intent to continue use. The judge found that the applicant demonstrated a clear understanding of federal law after being educated during his background interview.
The decision to grant clearance was based on several mitigating factors. The applicant provided credible testimony and a written commitment to abstain from future drug use, which the judge found sincere. Additionally, his past drug use was infrequent and occurred under circumstances deemed unlikely to recur, thereby mitigating the security concerns.
Why the Applicant Prevailed
- The applicant demonstrated a clear understanding of the legal implications of drug use under federal law after being educated during the background interview.
- He provided credible testimony and a written commitment to abstain from future drug use, which the judge found sincere and binding.
- The applicant's past drug use was infrequent and occurred under circumstances that were unlikely to recur, mitigating the security concerns.
Conditions Referenced
- AG ¶ 25(a)raisedSubstance Misuse
- AG ¶ 25(c)raisedIllegal Possession of a Controlled Substance
- AG ¶ 25(g)raisedIntent to Continue Drug Involvement
- AG ¶ 26(a)appliedBehavior Unlikely to Recur
- AG ¶ 26(b)appliedAcknowledgment of Drug Involvement and Commitment to Abstain
Key Rule Quoted
“The protection of the national security is the paramount consideration.”
Procedural Posture
- SOR issuedJun 25, 2021
- Answer filedJan 7, 2021
- Hearing heldMay 24, 2022via video teleconference
- Decision dateJul 22, 2022
Cite For
- Mitigating Factors for Drug Involvement Under Guideline H
- Understanding of State Versus Federal Law Regarding Drug Use
- Commitment to Abstain From Drug Use as a Mitigating Condition